Engineering News

Dr. Reddy's Buys Part of Dowpharma Unit
Tuesday April 1, 7:50 am ET

Dr. Reddy's Laboratories Buys Part of Dowpharma Small Molecules Division From Dow Chemical

NEW YORK (AP) -- Indian drug maker Dr. Reddy's Laboratories Ltd. said Tuesday it purchased part of the Dowpharma small molecules unit from Dow Chemical Co. to enhance its offerings.

Terms were not disclosed.

The transaction includes relevant business, customer contracts, associated products, process technology, intellectual property, trademarks and the transfer of plants located at Mirfield and Cambridge, United Kingdom.

Dr. Reddy's will also obtain a non-exclusive license for Dow's Pfenex Expression Technology for biocatalysis development as part of the deal. Biocatalysis uses enzymes to perform chemical transformations on organic compounds.

The acquisition is subject to regulatory approval and is expected to close on April 30.

Source: Associated Press

Engineering News Archive

 
// CAREER RESOURCES

Applicant Procedures
Job Seekers
Resume Help
Professional Organizations
Engineering Career Information
Engineering Colleges

// WHAT WE DO
Recruiters for
Professionals in the Chemical
& Pharmaceutical Industries
We recruit exclusively for Engineers and Operations/Maintenance Management Personnel in the following areas:
Specialty chemicals
Bulk chemicals
Commodity Chemicals
Petrochemicals
Fine chemicals
Agrochemicals
Industrial gases
Surfactants
Fertilizers
Solvents
Coatings
Polymers
Pharmaceuticals
Refinery
Career Center | FAQs | Privacy
SESI Corporate Headquarters (954)755-3121 ext 109
© Search Enterprises, Inc. All rights reserved.
Industry News Career Center FAQs Submit a Job About Search Enterprises Submit a Resume Candidates Job Opportunities Search Enterprises Home